Ozone the one and only drug

Area of Science:

• Minimally Invasive Surgery
• Regenerative Medicine
• Pain Management

Background:

• Ozone therapy is recognized for its therapeutic properties.
• Evidence supports the long-term use of ozone for medical treatments.
• Back pain, particularly from discal hernia, remains a significant clinical challenge.

Purpose of the Study:

• To evaluate the efficacy of ozone therapy as a standalone treatment for discal hernia.
• To compare ozone therapy outcomes with traditional physiatric and kinetic treatments.
• To assess the long-term results of ozone treatment for spinal conditions.

Main Methods:

• A study involving 270 patients with discal hernia treated with intradiscal and periganglionic oxygen-ozone mixture (30 mg/ml).
• Minimally invasive procedures performed under real-time fluoroscopic guidance.
• A control group of 120 patients received physiatric and kinetic treatment (magnetotherapy).
• Patient follow-up over 3 months using MacNab, VAS, and Owestry scales from April 2004 to July 2008.

Main Results:

• Ozone therapy yielded 86% excellent results, 12% satisfactory results, and 2% poor results.
• The treatment was administered as the sole therapeutic agent in the primary group.
• Significant improvements were observed in patient-reported outcomes and pain reduction.

Conclusions:

• Ozone therapy presents a promising and effective minimally invasive option for treating discal hernia.
• The study highlights the potential of ozone therapy in revolutionizing back pain management.
• Further research into new applications, concentrations, and combination therapies is warranted.